Unhealthy lifestyle may increase later depression via inflammation in older women but not men

Journal of Psychiatric Research

Volumn 63, Issue , 2015, Pages 65-74

  Hiles, Sarah A ^a   Baker, Amanda L ^a   de Malmanche, Theo ^b   McEvoy, Mark ^c,d   Boyle, Michael ^d   Attia, John ^c,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d JOHN HUNTER HOSPITAL   (Australia)

Author keywords

C reactive protein; Cohort; Depression; Inflammation; Interleukin; Prospective

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; SATURATED FATTY ACID;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BODY MASS; COHORT ANALYSIS; COPING BEHAVIOR; DEPRESSION; ENERGY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; INDEPENDENT LIVING; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGIC ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING; SOCIAL PSYCHOLOGY; WAIST HIP RATIO; AUSTRALIA; BLOOD; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE COURSE; METABOLISM; MIDDLE AGED; PSYCHOLOGY; RETROSPECTIVE STUDY; SELF REPORT; SEXUAL DEVELOPMENT;

AGED; AUSTRALIA; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIFE STYLE; MALE; MIDDLE AGED; QUALITY OF LIFE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SELF REPORT; SEX CHARACTERISTICS;

EID: 84926408548     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.02.010     Document Type: Article

References (66)

1. Akhondzadeh S., Jafari S., Raisi F., Nasehi A.A., Ghoreishi A., Salehi B., et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 2009, 26:607-611.
2. Anisman H., Merali Z., Poulter M.O., Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des 2005, 11:963-972.
3. Azevedo Da Silva M., Singh-Manoux A., Brunner E.J., Kaffashian S., Shipley M.J., Kivimäki M., et al. Bidirectional association between physical activity and symptoms of anxiety and depression: the Whitehall II study. Eur J Epidemiol 2012, 27:537-546.
4. Bastard J.-P., Maachi M., Lagathu C., Ji Kim M., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
5. Beekman A., Deeg D.J.H., Van Limbeek J., Braam A.W., De Vries M.Z., Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med 1997, 27:231-235.
6. Berk M., Williams L., Jacka F., O'Neil A., Pasco J., Moylan S., et al. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med 2013, 11:200.
7. Boyle S.H., Jackson W.G., Suarez E.C. Hostility, anger, and depression predict increases in C3 over a 10 year period. Brain Behav Immun 2007, 21:816-823.
8. Calay E.S., Hotamisligil G.S. Turning off the inflammatory, but not the metabolic, flames. Nat Med 2013, 19:265-267.
9. Capuron L., Fornwalt F.B., Knight B.T., Harvey P.D., Ninan P.T., Miller A.H. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?. JAffect Disord 2009, 119:181-185.
10. Clyne B., Olshaker J.S. The C-reactive protein. JEmerg Med 1999, 17:1019-1025.
11. Copeland W.E., Shanahan L., Worthman C., Angold A., Costello E.J. Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. Psychol Med 2012, 42:2641-2650.
12. Cumming R.G., Mitchell P. Alcohol, smoking and cataracts: The Blue Mountains Eye Study. Arch Ophthalmol 1997, 115:1296-1303.
13. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
14. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. Ameta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
15. Duivis H.E., de Jonge P., Penninx B.W., Na BYC B.E., Whooley M.A. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the Heart and Soul Study. Am J Psychiatry 2011, 168:913-920.
16. Edwards K.M., Burns V.E., Ring C., Carroll D. Sex differences in the interleukin-6 response to acute psychological stress. Biol Psychol 2006, 71:236-239.
17. Everson-Rose S.A., Lewis T.T., Karavolos K., Dugan S.A., Wesley D., Powell L.H. Depressive symptoms and increased visceral fat in middle-aged women. Psychosom Med 2009, 71:410-416.
18. Ewald B., McEvoy M., Attia J. Pedometer counts superior to physical activity scale for identifying health markers in older adults. Br J Sports Med 2010, 44:756-761.
19. Food Standards Australia New Zealand NUTTAB 2006 Australian Food Composition Tables 2006, Department of Health and Ageing, Canberra, ACT, Australia.
20. Hamer M., Molloy G.J., de Oliveira C., Demakakos P. Leisure time physical activity, risk of depressive symptoms, and inflammatory mediators: the English Longitudinal Study of Ageing. Psychoneuroendocrinology 2009, 34:1050-1055.
21. Hamer M., Molloy G.J., de Oliveira C., Demakakos P. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship?. Brain Behav Immun 2009, 23:413-418.
22. Hickman R.J., Khambaty T., Stewart J.C. C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. JBehav Med 2014, 37:621-629.
23. Hiles S.A., Baker A.L., de Malmanche T., Attia J. Ameta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav Immun 2012, 26:1180-1188.
24. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
25. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007, 21:374-383.
26. Kaestner F., Hettich M., Peters M., Sibrowski W., Hetzel G., Ponath G., et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. JAffect Disord 2005, 87:305-311.
27. King D.E., Egan B.M., Geesey M.E. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 2003, 92:1335-1339.
28. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol Psychiatry 2005, 69:113-132.
29. Larsson C., Gullberg B., Rastam L., Lindblad U. Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study. BMC Endocr Disord 2009, 9:16.
30. Lopresti A.L., Hood S.D., Drummond P.D. Areview of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. JAffect Disord 2013, 148:12-27.
31. Marcus S.M., Young E.A., Kerber K.B., Kornstein S., Farabaugh A.H., Mitchell J., et al. Gender differences in depression: findings from the STAR* D study. JAffect Disord 2005, 87:141-150.
32. Marriott I., Huet-Hudson Y. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 2006, 34:177-192.
33. Matthews K.A., Schott L.L., Bromberger J.T., Cyranowski J.M., Everson-Rose S.A., Sowers M. Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition. Psychosom Med 2007, 69:124-130.
34. Matthews K.A., Schott L.L., Bromberger J.T., Cyranowski J.M., Everson-Rose S.A., Sowers M. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women?. Brain Behav Immun 2010, 24:96-101.
35. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314:1-16.
36. McConnell J.P., Branum E.L., Ballman K.V., Lagerstedt S.A., Katzmann J.A., Jaffe A.S. Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods. Clin Chem Lab Med 2005, 40:56-59.
37. McEvoy M., Smith W., D'Este C., Duke J., Peel R., Schofield P., et al. Cohort profile: the Hunter Community Study. Int J Epidemiol 2010, 39:1452-1463.
38. Milaneschi Y., Corsi A.M., Penninx B.W., Bandinelli S., Guralnik J.M., Ferrucci L. Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study. Biol Psychiatry 2009, 65:973-978.
39. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
40. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011, 70:663-671.
41. Modabbernia A., Taslimi S., Brietzke E., Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 2013, 74:15-25.
42. Myint A.M., Schwarz M.J., Steinbusch H.W.M., Leonard B.E. Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis 2009, 24:55-68.
43. National Health and Medical Research Council Australian alcohol guidelines: health risks and benefits 2001, Australian Government, Canberra, Australia.
44. National Health and Medical Research Council and Department of Health and Ageing Australian Government Dietary guidelines for Australians: a guide to healthy eating 2005, Australian Government, Canberra, Australia.
45. O'Connor M.-F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., Hamby M.E., et al. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun 2009, 23:887-897.
46. O'Donovan A., Rush G., Hoatam G., Hughes B.M., McCrohan A., Kelleher C., et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety 2013, 30:307-314.
47. Odegaard J.I., Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013, 339:172-177.
48. Payette C., Blackburn P., Lamarche B., Tremblay A., Bergeron J., Lemieux I., et al. Sex differences in postprandial plasma tumor necrosis factor-α, interleukin-6, and C-reactive protein concentrations. Metabolism 2009, 58:1593-1601.
49. Preacher K.J., Hayes A.F. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods, Instrum Comput 2004, 36:717-731.
50. Radloff L.S. The CES-D scale. Appl Psychol Meas 1977, 1:385-401.
51. Raison C.L., Miller A.H. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry 2013, 18:15-37.
52. Raison C.L., Rutherford R.E., Woolwine B.J., Shuo C., Schettler P., Drake D.F., et al. Arandomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013, 70:31-41.
53. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001, 58:445-452.
54. Richardson J., Peacock S., Hawthorne G., Iezzi A., Elsworth G., Day N. Construction of the descriptive system for the assessment of quality of life AQoL-6D utility instrument. Health Qual Life Outcomes 2012, 10:38.
55. Rothermundt M., Arolt V., Fenker J., Gutbrodt H., Peters M., Kirchner H. Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 2001, 251:90-97.
56. Skinner H.A. Development and validation of a lifetime alcohol consumption assessment procedure 1982, Addiction Research Foundation, Toronto, ON, Canada.
57. Slavich G.M., Irwin M.R. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 2014, 140:774-815.
58. Smith W., Mitchell P., Reay E.M., Webb K., Harvey P.W.J. Validity and reproducibility of a self-administered food frequency questionnaire in older people. Aust N Z J Public Health 1998, 22:456-463.
59. Sobell M.B., Maisto S.A., Sobell L.C., Cooper A.M., Cooper T., Sanders B. Developing a prototype for evaluating alcohol treatment effectiveness. Evaluating alcohol and drug abuse treatment effectiveness: recent advances 1979, Pergamon Press, New York. L.C. Sobell, M.B. Sobell, E. Ward (Eds.).
60. Song M.R., Lee Y.-S., Baek J.-D., Miller M. Physical activity status in adults with depression in the National Health and Nutrition Examination Survey, 2005-2006. Public Health Nurs 2012, 29:208-217.
61. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574.
62. Thorand B., Baumert J., Döring A., Herder C., Kolb H., Rathmann W., et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006, 184:216-224.
63. U.S.Department of Agriculture and U.S.Department of Health and Human Services Dietary guidelines for Americans 2010, U.S. Government Printing Office, Washington, DC. 7th ed.
64. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. JAffect Disord 2013, 150:736-744.
65. Vogelzangs N., Beekman A.T.F., de Jonge P., Penninx B.W.J.H. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry 2013, 3:e249.
66. World Health Organization Draft Comprehensive Global Monitoring Framework and targets for the prevention and control of noncommunicable diseases 2013, World Health Organization.